SUBSCRIBE

Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

News > Research

Read more breaking news

 

 

Review links ulcerous stomach bacteria with obesity

By Annie-Rose Harrison-Dunn+

02-Jun-2014
Last updated on 03-Jun-2014 at 12:26 GMT2014-06-03T12:26:04Z

“The gradual decrease of the H. pylori colonisation observed in recent decades could be causally related to the obesity endemic observed in the Western world,” according to researcher.
“The gradual decrease of the H. pylori colonisation observed in recent decades could be causally related to the obesity endemic observed in the Western world,” according to researcher.

The gradual decrease of the ulcer-causing stomach bacteria Helicobacter pylori could be linked to the global obesity endemic, according to an international research review. 

The review – which gathered data from 50 studies from ten different European countries, Japan, the US and Australia published between 1990 and 2012 – looked at the impact of treatment of the stomach bacteria Helicobacter pylori (H. pylori), which can cause stomach ulcers. It suggested a correlation between prevalence rates of H. pylori and and weight gain in developed countries.

Professor Gerald Holtmann from the department of gastroenterology and hepatology at the Princess Alexandra Hospital in Australia, who led the review, said: “The rate of obesity and overweight were inversely and significantly correlated with the prevalence of H. pylori infection.”

“The gradual decrease of the H. pylori colonisation observed in recent decades could be causally related to the obesity endemic observed in the Western world,” he said.

However the researchers said that other factors linked to H. pylori aside from infection could also explain this association with obesity. "Thus the role that the gastrointestinal microbiome may play needs to be properly addressed. It is well established that there is an interplay between diet, microbiome and health," they wrote. 

An emerging debate

The review, published in Alimentary Pharmacology & Therapeutics, followed what it called an “emerging debate” over the affect of H. pylori infection on body mass index (BMI).

Of the reviewed studies, the mean H. pylori rate was 44.1%, with a range of 17–75%, while the average rates for obesity and the overweight were 46.6% and 14.2%, respectively. The results suggested an inverse, significant correlation between these two data sets.

According to the researchers, 50% of the global population may be infected with H. pylori, but only 20% of this group experience symptoms. If symptoms do occur, they may be that of peptic ulcer disease which can mean fullness, bloating, early satiety and nausea.

The researchers said while it was possible to speculate weight gain was due to the clear-up of these satiety symptoms, well-controlled studies included in the review meant this was unlikely. They suggested that the correlation could instead be due to an increase in the hunger hormone, ghrelin.

Interestingly, in one study, plasma ghrelin increased profoundly in asymptomatic subjects after H. pylori cure.This could lead to increased appetite and consequently weight gain, and contribute to the increasing obesity seen in Western populations where H. pylori prevalence is low,” they wrote. 

The researchers adjusted to account for gross domestic product of the subjects, which they said ruled out the possibility that the association was simply mediated by the income or the development status of the populations included in the analysis. 

Studies focusing on non-random samples or patient cohorts with H. pylori-associated diseases were excluded from the review. 

 

Source: Alimentary Pharmacology & Therapeutics
Published online ahead of print, doi: 10.1111/apt.12790
'Review article: associations between Helicobacter pylori and obesity - an ecological study'
N. Lender, N. J. Talley, P. Enck, S. Haag, S. Zipfel, M. Morrison, G. J. Holtmann

Related products

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Fytexia
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Indena
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Capsugel
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Ingredion
Balancing Innovation and Risk in Sports Nutrition Ingredients
NSF-International
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Roquette
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars